Costa Rica's Pharmaceutical Market is Dominated by Foreign Branded Drugs in the Private Market and Generics in the Public Market (CCSS)

Research and Markets (researchandmarkets.com/reports/c8735) has announced the addition of Costa Rica Outlook Pharmaceutical Country Intelligence Report to their offering.

(PRWEB) November 6, 2004 -- World Pharma Markets Outlook Reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets worldwide. Each report provides a comprehensive analysis of the market and, importantly, provides 5-year market forecasts, national data projections, outlook and key developments such as regulation, pricing/reimbursement, health facilities and government policy. Importantly, the market can be seen in its global context with international market comparisons.

Costa Rica has a small but open pharmaceutical market dominated by foreign branded drugs in the private market, and generics in the public market (CCSS). New agreements such as the Central America-US Free Trade Agreement (CAFTA), if enforced, will be likely to result in a further adoption of international standards on intellectual property rights, which will mean a further control on drug quality, efficiency and safety, diminishing the already fragmented local generics market

The contents of this report are as follows:
1.Executive Summary
2.Pharmaceutical Market
3.Key National Data Projections
4.Sources

For more information visit http://www.researchandmarkets.com/reports/c8735

Laura Wood
Senior Manager
Research and Markets
press@researchandmarkets.com
Fax: +353 1 4100 980

###